Skip to main content
Semler Scientific, Inc. logo

Semler Scientific, Inc. — Investor Relations & Filings

Ticker · SMLR ISIN · US81684M1045 LEI · 549300ZHL16S29QTW485 US Professional, scientific and technical activities
Open in API
Filings indexed 864 across all filing types
Latest filing 2014-01-02 Capital/Financing Update
Country US United States of America
Listing US SMLR

About Semler Scientific, Inc.

https://www.semlerscientific.com/

Semler Scientific, Inc. is a company that develops, manufactures, and markets technology solutions to improve the clinical effectiveness and efficiency of healthcare providers. Its primary focus is on products and services that support the early detection and treatment of chronic diseases. The company's flagship product is a patented, FDA-cleared system that provides a rapid, point-of-care test to aid in the diagnosis of peripheral artery disease (PAD). In addition to its healthcare technology operations, the company has adopted a corporate strategy to acquire and hold bitcoin as its primary treasury reserve asset.

Recent filings

Filing Released Lang Actions
AMENDMENT NO. 2 TO FORM S-1
Capital/Financing Update Classification · 100% confidence The document is an Amendment No. 2 to Form S-1 filed with the SEC, which is a registration statement under the Securities Act of 1933. It is related to an initial public offering (IPO) of common stock by Semler Scientific, Inc. The text includes detailed information about the company, its business, product, market opportunity, and offering details. Form S-1 and its amendments are filings related to capital raising and securities registration, not financial reports like annual or quarterly reports. Therefore, this document is best classified as a Capital/Financing Update (CAP) because it pertains to the company's fundraising activities through an IPO registration statement.
2014-01-02 English
Regulatory Filings 2013
Regulatory Filings
2013-12-19 English
Regulatory Filings 2013
Regulatory Filings Classification · 100% confidence The document is a letter dated December 6, 2013, from a law firm representing Semler Scientific, Inc., responding to comments from the U.S. Securities and Exchange Commission (SEC) staff regarding the company's Registration Statement on Form S-1 filed on November 15, 2013. The letter addresses detailed comments on disclosures, product descriptions, market opportunity, use of proceeds, related-party transactions, and other regulatory compliance matters related to the S-1 registration statement. The document is not a financial report, earnings release, or management discussion but rather a regulatory correspondence responding to SEC review comments on a registration filing. This type of document fits best under Regulatory Filings (RNS), which includes compliance documents and correspondence with regulatory bodies that do not fit other specific categories. The document length (12,571 characters) and content confirm it is not a brief announcement or a report publication announcement but a substantive regulatory filing response.
2013-12-06 English
AMENDMENT NO. 1 TO FORM S-1
Capital/Financing Update Classification · 100% confidence The document is an Amendment No. 1 to Form S-1, which is a registration statement filed with the SEC under the Securities Act of 1933. It is related to an initial public offering (IPO) of common stock by Semler Scientific, Inc. The text includes detailed information about the offering, the company, its business, financials, management, and legal matters. Form S-1 and its amendments are registration statements used for securities offerings and are not annual reports, earnings releases, or other financial reports. This filing is best classified under Capital/Financing Update (CAP) because it pertains to the company's fundraising activities through an IPO registration statement.
2013-12-06 English
Regulatory Filings 2013
Regulatory Filings
2013-12-02 English
Regulatory Filings 2013
Regulatory Filings Classification · 95% confidence The document is a detailed letter from a law firm responding to comments from the U.S. Securities and Exchange Commission (SEC) regarding a Draft Registration Statement on Form S-1 for Semler Scientific, Inc. The letter addresses SEC staff comments on various disclosures, financial data, risk factors, business overview, and accounting policies. It references the Registration Statement on Form S-1, which is a filing used for initial public offerings (IPOs) and other securities registrations. The document is not the Registration Statement itself but a correspondence responding to SEC comments on the draft. It contains no financial statements or substantive financial data but rather explanations and revisions to be made in the Registration Statement. Therefore, this document is best classified as a Regulatory Filing (RNS), which covers general regulatory announcements, compliance documents, and miscellaneous filings that do not fit other categories. The document is not an Annual Report, Interim Report, Earnings Release, or any other specific report type. It is also not a Report Publication Announcement since it is a letter responding to SEC comments, not an announcement of report publication.
2013-11-15 English

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.